Acta Biomaterialia, Journal Year: 2022, Volume and Issue: 155, P. 554 - 563
Published: Sept. 8, 2022
Language: Английский
Acta Biomaterialia, Journal Year: 2022, Volume and Issue: 155, P. 554 - 563
Published: Sept. 8, 2022
Language: Английский
Advanced Functional Materials, Journal Year: 2023, Volume and Issue: 34(13)
Published: Dec. 21, 2023
Abstract Almost all cancer treatments are significantly limited by the strong tumor microenvironment (TME) fortress formed abnormal vasculature, dense extracellular matrix (ECM), multidrug resistance (MDR) system, and immune “cold” environment. In huge efforts of dismantling TME fortress, nitric oxide (NO)‐based nanomedicines increasingly occupying a central position have already been identified as super “strong polygonal warriors” to dismantle for efficient treatment, benefiting from NO's unique physicochemical properties extremely fascinating biological effects. However, there is paucity systematic review elaborate on progress fundamental mechanism NO‐based in oncology this aspect. Herein, key characteristics potential NO reprogramming delineated highlighted. The evolution donors advantages discussed subsequently. Moreover, latest solid tumors comprehensively reviewed, including normalizing overcoming ECM barrier, reversing MDR, reactivating immunosuppression TME. Lastly, prospects, limitations, future directions manipulation provide new insights into construction more applicable anticancer nanomedicines.
Language: Английский
Citations
16Acta Biomaterialia, Journal Year: 2023, Volume and Issue: 162, P. 57 - 71
Published: March 20, 2023
Language: Английский
Citations
14Acta Biomaterialia, Journal Year: 2023, Volume and Issue: 174, P. 1 - 25
Published: Dec. 12, 2023
Language: Английский
Citations
14Small, Journal Year: 2022, Volume and Issue: 19(4)
Published: Nov. 24, 2022
The interaction between platelets and circulating tumor cells (CTCs) contributes to distal metastasis by protecting CTCs from immunological assault shear stress, which can be disrupted nitric oxide (NO) through inhibiting platelet-mediated adhesion. To eradicate primitive tumors inhibit CTC-based pulmonary metastasis, a novel biomimetic nanomedicine (mCuMNO) is designed encapsulating Cu+ -responsive S-nitrosoglutathione as NO donor into copper-based metal-organic framework (CuM). This work discovers that mCuMNO target regions deplete local glutathione (GSH) reduce Cu2+ , followed triggering release hydroxyl radicals (·OH) production, thereby interrupting platelet/CTC interplay contributing chemodynamic therapy. Detailed studies demonstrate exhibits high efficiency safety in therapy antimetastasis activity, sheding new light on the development of CuM-based synthetic
Language: Английский
Citations
22Acta Biomaterialia, Journal Year: 2022, Volume and Issue: 155, P. 554 - 563
Published: Sept. 8, 2022
Language: Английский
Citations
20